Immune thrombocytopenia (ITP): vizsgálatok itt: Egyesült Államok
19 trials · From ClinicalTrials.gov, checked 2026. november 13.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleStudy to Evaluate the Efficacy and Safety of Oral Rilzabrutinib in Adults With Immune Thrombocytopenia (ITP) Who Failed First-line Treatment
- Where
- Albany, Ann Arbor, Boston, Clovis, Danvers, Greenville, Los Angeles, Minneapolis, New Orleans, Ogden, Peoria, Portland, Rochester, Seattle, The Bronx, Torrance, Washington D.C.
- Életkor
- 18 év and over
- People
- 60 worldwide
- Run by
- Sanofi
See details and how to joinNCT07007962 · EU 2025-522070-36-00 - 2. fázisTaking peopleA Study to Assess the Tolerability of Ianalumab (VAY736) With Investigator's Choice Thrombopoietin Receptor Agonist (IC TPO-RA) in Patients With Primary Immune Thrombocytopenia (ITP)
- Where
- Billings, Chandler, Covington, Durham, East Brunswick, Fayetteville, Fort Worth, Hinsdale, Jacksonville, Kansas City, Margate, Miami, New Haven, Orlando, Philadelphia, Pittsburgh, Rochester, Salt Lake City, Sioux Falls, Stamford, Summit, The Bronx, Torrance
- Életkor
- 18 év and over
- People
- 164
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07421167 - 1/2. fázisTaking peopleA Study of Pirtobrutinib in Participants With Immune Thrombocytopenia
- Where
- Austin, Houston, Los Angeles, Miami, New Orleans, Palo Alto, Peoria, Rochester, The Woodlands, Washington D.C.
- Életkor
- 18 év to 64 év
- People
- 68 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT06721013 · EU 2024-518502-40-00 - 3. fázisTaking peopleA Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- Where
- Atlanta, Bethesda, Boston, Cleveland, Denver, Durham, Greenville, Hot Springs, Houston, Indianapolis, Iowa City, Kansas City, Los Angeles, Louisville, Milwaukee, New York, Norfolk, Philadelphia, Portland, San Diego, Seattle, The Bronx, Washington D.C., Worcester
- Életkor
- 18 év and over
- People
- 171 worldwide
- Run by
- Takeda
See details and how to joinNCT06722235 · EU 2024-514401-54-00 - 3. fázisTaking peopleA Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- Where
- Atlanta, Boston, Cleveland, Denver, Durham, Greenville, Hot Springs, Houston, Indianapolis, Iowa City, Kansas City, Los Angeles, Louisville, Milwaukee, Morristown, New York, Norfolk, Philadelphia, Portland, San Diego, Seattle, The Bronx, Washington D.C., Worcester
- Életkor
- 18 év and over
- People
- 150 worldwide
- Run by
- Takeda
See details and how to joinNCT06948318 · EU 2025-521692-31-00 - 2. fázisTaking peopleStudy to Assess the Safety and Tolerability of Tafasitamab in Adult Participants With Primary Autoimmune Blood Cell Disorders
- Where
- Boston, Cooper City, Fairfax, Glendale, Lone Tree, Los Angeles, New Haven, Seattle, The Bronx
- Életkor
- 18 év and over
- People
- 56 worldwide
- Run by
- Incyte Corporation
See details and how to joinNCT07104565 · EU 2025-521286-27-00 - 3. fázisTaking peopleA Study Investigating Intravenous Human Normal Immunoglobulin 10% in Adults With Chronic Immune Thrombocytopenia (ITP)
- Where
- Greenville, Los Angeles, Shirley
- Életkor
- 18 év to 70 év
- People
- 40 worldwide
- Run by
- Kedrion S.p.A.
See details and how to joinNCT07059000 · EU 2023-507115-35-00 - 1/2. fázisTaking peopleSafety and Preliminary Efficacy of CTX112 in Adult Participants With Relapsed/Refractory Hematologic Autoimmune Disease
- Where
- Boston, Omaha, Rochester
- Életkor
- 18 év and over
- People
- 60 worldwide
- Run by
- CRISPR Therapeutics AG
See details and how to joinNCT07549698 - No phaseTaking peopleCognitive Dysfunction in Chronic and Persistent Immune Thrombocytopenia
- Where
- Boston
- Életkor
- 18 év and over
- People
- 100
- Run by
- Massachusetts General Hospital
See details and how to joinNCT06817395 - No phaseCsak meghívásosComparative Autoantibody and Immunologic Cell Marker Study
- Where
- Atlanta
- Életkor
- 18 év and over
- People
- 2500
- Run by
- Emory University
See details and how to joinNCT02422875 - No phaseTaking peopleA Study of Patients' Preferences for Primary Immune Thrombocytopenia Treatment
- Where
- East Hanover
- Életkor
- 18 év and over
- People
- 100
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07786077 - 3. fázisTaking peopleA Study of Romiplostim Plus Predniso(lo)ne vs. Predniso(lo)ne Alone for the Treatment of Previously Untreated Primary Immune Thrombocytopenia (ITP)
- Where
- Fredericksburg, Long Beach, Peoria
- Életkor
- 18 év to 100 év
- People
- 126
- Run by
- Amgen
See details and how to joinNCT07700238 - 2. fázisTaking peopleSafety, Tolerability, and Efficacy of NVG-2089 in Participants With Immune Thrombocytopenia
- Where
- Boston, Greenville, Washington D.C.
- Életkor
- 18 év to 80 év
- People
- 30 worldwide
- Run by
- Nuvig Therapeutics, Inc.
See details and how to joinNCT07095127 · EU 2024-520359-26-00 - 1. fázisTaking peopleOM336 in Autoimmune Cytopenias
- Where
- Ann Arbor, Duarte, Seattle, Washington D.C.
- Életkor
- 18 év to 75 év
- People
- 32 worldwide
- Run by
- Lakefront Biotherapeutics West LLC
See details and how to joinNCT07083960 - 1/2. fázisNot yet taking people in Egyesült ÁllamokA Phase 1b/2a Study of Velinotamig in Adults With Relapsed/Refractory ITP and wAIHA
- Where
- Webster
- Életkor
- 18 év to 80 év
- People
- 72
- Run by
- Cullinan Therapeutics Inc.
See details and how to joinNCT07738822 - 1. fázisTaking peoplePhase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)
- Where
- Amarillo, Austin, Baltimore, Chapel Hill, Columbus, Houston, Lake Success, New York, Orange, Philadelphia, Portland
- Életkor
- 18 év to 85 év
- People
- 144 worldwide
- Run by
- Chugai Pharmaceutical
See details and how to joinNCT06371417 · EU 2023-507692-21-00 - 2. fázisNot yet taking people in Egyesült ÁllamokStudy of Zola-cel (BMS-986353), in Participants With Autoimmune Cytopenia (Breakfree-AiCE)
- Where
- Boston, Houston, Seattle
- Életkor
- 18 év and over
- People
- 52 worldwide
- Run by
- Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
See details and how to joinNCT07603557 - 3. fázisTaking peopleA Study to Assess the Efficacy and Safety of Efgartigimod IV in Adult Participants With Primary Immune Thrombocytopenia
- Where
- Aurora, Chicago, Cleveland, Columbus, Detroit, Durham, Greenville, Iowa City, Little Silver, Los Angeles, Minneapolis, New Haven, New Orleans, Oceanside, Oklahoma City, Phoenix, Washington D.C., Westbury
- Életkor
- 18 év and over
- People
- 69 worldwide
- Run by
- argenx
See details and how to joinNCT06544499 · EU 2024-515451-38-00 - 1. fázisTaking peopleDose Dense Rituximab for High Risk Newly Diagnosed Acute Immune Thrombocytopenic Purpura
- Where
- Vahalla
- Életkor
- 1 év to 21 év
- People
- 20
- Run by
- New York Medical College
See details and how to joinNCT04323748